MedPage Today on MSN
First TAVR System Approved for Severe Aortic Regurgitation
Limited launch expected for JenaValve's Trilogy System ...
COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc. today announced successful results in an additional 5 patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV™) ...
NORRISTOWN, Pa.--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc., announced today successful 30-day outcomes in the first two patients receiving the Optimum Transcatheter Aortic Valve (Optimum TAV™).
Thubrikar Aortic Valve, Inc. today announced authorization from the Competent Authority of Poland to expand the TAVI-1 CE Mark trial of the Optimum Transcatheter Aortic Valve Implantation System™ ...
The Lancelot technology delivers enhanced hemodynamics through the integration of precision laser cutting and after ...
In patients with bicuspid aortic stenosis who are at low surgical risk, TAVI with a contemporary balloon-expandable valve provides outcomes similar to those achieved in patients who have tricuspid ...
Aortic valve disease is a condition that occurs when your aorta (the main artery of your body) and left ventricle (the lower left chamber of your heart) malfunction. The aortic valve determines how ...
BACKGROUND: Aortic valve calcification increases leaflet stiffness and contributes to the development of calcific aortic valve disease. The molecular and cellular mechanisms underlying calcification ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results